Similar articles

• [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2003 May 29;145(22):51. MMW Fortschr Med. 2003. PMID: 12866281 German. No abstract available.
• Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.

  Day JH, Briscoe M, Widlitz MD. Day JH, et al. J Allergy Clin Immunol. 1998 May;101(5):638-45. doi: 10.1016/S0091-6749(98)70172-1. J Allergy Clin Immunol. 1998. PMID: 9600501 Clinical Trial.
• [Peripheral anticholinergic syndrome].

  Valencia Zavala MP, Vega Robledo GB, Sánchez Olivas JA, Sánchez Olivas MA, Montes Montes J, Duarte Díaz RJ, León Oviedo C. Valencia Zavala MP, et al. Rev Alerg Mex. 2007 Mar-Apr;54(2):66-9. Rev Alerg Mex. 2007. PMID: 17542247 Spanish.
• [Oral second generation antihistamines in allergic rhinitis].

  Riechelmann H. Riechelmann H. Laryngorhinootologie. 2005 Jan;84(1):30-41. doi: 10.1055/s-2004-826000. Laryngorhinootologie. 2005. PMID: 15647976 Review. German.
• A review of the second-generation antihistamine ebastine for the treatment of allergic disorders.

  Van Cauwenberge P, De Belder T, Sys L. Van Cauwenberge P, et al. Expert Opin Pharmacother. 2004 Aug;5(8):1807-13. doi: 10.1517/14656566.5.8.1807. Expert Opin Pharmacother. 2004. PMID: 15264995 Review.